<
AI
Automation
Science
Innovation
Open Source
Blockchain
Social Media
Startups
Culture
Cloud
>

Destination
Crispr Pioneer Launches Startup to Make Tailored Gene-Editing Treatments

Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases. [...]

Discover Copy
Rating

Innovation

Pricing

Technology

Usability

We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.

Destination
Doctors successfully treated a baby with the first ever personalized gene-editing therapy

A team of doctors and scientists have successfully treated a rare genetic condition with the first-ever personalized gene-editing therapy. Results of the groundbreaking treatment have been published i [...]

Match Score: 185.37

Destination
CRISPR can stop malaria spread by editing a single gene in mosquitos

CRISPR gene-editing therapy has shown great potential to treat and even cure diseases, but scientists are now discovering how it can be used to prevent them as well. A team of researchers found a way [...]

Match Score: 184.34

Destination
VR is helping to make daunting medical treatments more bearable for patients

Stanley Johnson is not a fan of needles. The 67-year-old Air Force veteran has endured his fair share of pokes over the years, but when it was decided that IV infusions would be the best course of act [...]

Match Score: 49.34

Destination
The World’s First Crispr Drug Gets a Slow Start

The first medical treatment to use Crispr gene editing has been on the market for a year. Its complexity means few patients in the US have received it yet. [...]

Match Score: 45.92

Destination
A Baby Received a Custom Crispr Treatment in Record Time

Scientists were able to create a bespoke treatment for KJ Muldoon’s rare genetic disorder within six months. It could be a blueprint for potentially life-saving, gene-editing Crispr therapies. [...]

Match Score: 45.92

qz
Intellia is seeking FDA approval for what could be the first in vivo CRISPR gene editing therapy

The company's treatment for hereditary angioedema reduced attacks by 87% vs. placebo in a Phase 3 trial, clearing the way for a potential 2027 launch [...]

Match Score: 45.72

Destination
A Gene Editing Therapy Cut Cholesterol Levels by Half

An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease. [...]

Match Score: 45.51

Destination
Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene. [...]

Match Score: 42.89

Destination
The Next Era of Gene Editing Will Be Disease Agnostic

At the WIRED Health summit, pioneer David Liu said his lab is on the verge of revealing a new gene-editing technique that could target multiple unrelated diseases. [...]

Match Score: 40.23